NCT06281977View on ClinicalTrials.gov

Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm

PHASE3RecruitingINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

May 8, 2024

Primary Completion Date

May 8, 2027

Study Completion Date

August 1, 2027

Conditions
Ventricular TachycardiaVentricular ArrhythmiasVentricular FibrillationRecurrent Ventricular Tachycardia
Interventions
DRUG

Dexmedetomidine

Dose range: 0.3 mcg/kg/hr to 1 mcg/kg/hr.

DRUG

Normal saline

Programed as dexmedetomidine on infusion pump.

Trial Locations (1)

K1Y 4W7

RECRUITING

University of Ottawa Heart Institute, Ottawa

All Listed Sponsors
lead

Ottawa Heart Institute Research Corporation

OTHER